Having faced a long journey, it undoubtedly has been a fruitful one for SIRO. Keeping the vision in mind, the company continues to deliver in the global healthcare industry. Here are few milestones on the company’s path to consistent growth.
Introduced Medical Writing, Biostatistics
and Data Management service offerings
2002
Initiated a global, strategic partnership
with one of the largest global CRO’s
2007
Entry of private equity to promote SIRO’s growth
2008
Acquisition of German mid-sized Clinical Research
Organization to expand European operational
capabilities (subsequent closure of the company
in 2013 due to recession)
2011
Expanded operations in Asia with an office in Malaysia
2012
Opening of office in Princeton, New
Jersey to promote US business
2017
Buy back of entire company from investors and other shareholders by Dr. Gautam Daftary, to become 100% owner. Established a sales team in the U.S
2018
Inauguration of new GMP and GCP compliant Clinical Trials Supplies facility in India